Daniel Quesada (@drdquesada) profile picture

Cardiologo. Entusiasta de la Insuficiencia Cardíaca y la Rehabilitación Cardiaca. Hospital San Vicente de Paul. 🇨🇷

Costa Rica
Joined August 2018
Daniel Quesada retweeted
🌎 New #GlobalCardiacRehabAudit findings from Latin America & the Caribbean: ⚠️ Median coverage for incident #cardiac patients/country: 3% 💲 55% of patients pay out-of-pocket ❤️ Multidisciplinary staff of 5 delivered comprehensive care (9/10 components) 📖 bit.ly/3TnRiQM @BrazJPhysTher @ASSOBRAFIR @SUC_cardiologia @sccccardio @GlobalHeartHub @worldheartfed @gabrielamghisi @sherrylgrace @ClaudiaAnchique @drdquesada @pame_seron @AdawiTurk @LilianMbau @drMSupervia
9
10
191
#ACC26 is coming — I need your input 👇 ahead of my session If you could choose ONLY ONE drug to promote LV recovery in HFrEF… which would you prioritize? 🔄 RT so we can get more real-world 🌎 answers
44%ARNI
31%SGLT2i
7%MRA
18%BB
89 votes • Final results
3
7
14
992
Caffeine metabolism and why coffee hits people differently 1️⃣ Absorption Is Fast Caffeine is absorbed in the stomach & small intestine, peaking in blood within 30–60 min. 💡 why that morning espresso kicks in quick. 2️⃣ The Liver Is the Gatekeeper CYP1A2 enzyme (a liver detox enzyme) breaks caffeine down. 💡 Some people have a “fast” version, others a “slow” one. 3️⃣ Three Metabolites Dominate Paraxanthine → boosts alertness, fat metabolism. Theobromine → widens blood vessels (and is in chocolate). Theophylline → relaxes airways (like old asthma drugs). 4️⃣ Genetics Decide Your Buzz Fast metabolizers clear caffeine quickly (need more cups). Slow metabolizers keep caffeine in their system for hours (jitters, insomnia). 5️⃣ Lifestyle Tweaks It Smoking speeds caffeine breakdown. Pregnancy & certain meds slow it. 💡 Same coffee, different effects. 6️⃣ Half-Life Matters Caffeine’s half-life = ~5 hours, but in slow metabolizers it can stretch to 9+. 💡 That 3 p.m. latte may still be in your bloodstream at midnight. 7️⃣ Tolerance Builds Regular caffeine users adapt at the receptor level, needing more to feel the same effect. 💡 Why quitting leads to headaches & fatigue.
10
95
4
430
18,505
¡HOY! @cifacah los invita hoy al webinar: ESC 2025 Highlights en Falla Cardíaca por CIFACAH Resultados y su impacto en la Práctica Clínica. 🗓️ Martes 23 de septiembre 🕕 18:00 horas 🇨🇴 🔗Inscripción sin costo: us02web.zoom.us/webinar/regi… @SIAC_cardio @FallaCardiaca @sccccardio
5
9
516
Desde el Congreso Europeo de Cardiología, en Madrid 🇪🇸 El presidente de nuestro Consejo @cifacah Dr Walter Alarco 🇵🇪 @SIAC_cardio @sopecard1947 @rossel_victor @Bernilina @RiveraToquicaMD @EduardoPerna1
1
6
17
333
Hoy tuvimos nuestra Asamblea general Gracias por liderarnos en el periodo 2023-2025 como Presidente al Dr @rossel_victor y Secretario @EduardoPerna1 Acompañamos con entusiasmo a las nuevas autoridades: Presidente: Dr Walter Alarco @Walarco1 Secretario: Dr Daniel Quesada
7
16
594
Daniel Quesada retweeted
🌎 La Muerte Súbita Cardiaca es un desafío urgente en nuestra región. Desde ASOCAR, con el apoyo de SIAC, presentamos la Declaración de Costa Rica: una iniciativa que promueve el abordaje multidisciplinario de la Muerte Súbita en Centroamérica y Latinoamérica. 📢 Educación, prevención, registro y acceso a terapias: ejes clave para salvar vidas. 📄 Leé y compartí la declaración completa aquí 👉 siacardio.com/academia/advoc… 🤝 Agradecemos a la Asociación Costarricense de Cardiología por liderar este esfuerzo regional.
6
13
613
Felicitaciones por este gran trabajo y especialmente a mi amigo @pfelissamburu de @ICBAonline !!!!
🚨New Publication Alert: Our Landmark Study Published in the European Heart Journal! We’re proud to share that our latest study demonstrates that EchoGo® Amyloidosis, Ultromics’ FDA-cleared AI tool, significantly improves the detection of cardiac amyloidosis using a single echocardiographic video clip. 🫀 Cardiac amyloidosis is a frequently missed, life-threatening cause of heart failure. As new disease-modifying therapies emerge, early and accurate detection is more important than ever. 💡 EchoGo® Amyloidosis is: 💙 The first FDA-cleared AI screening tool for cardiac amyloidosis 💙 Granted Breakthrough Device designation 💙 Validated in a large, multi-center, international study (n = 2,719) 💙 Highly accurate with 85% sensitivity and 93% specificity across AL, ATTRwt, and ATTRv 💙 Demonstrated superior performance vs traditional scoring systems 🌍 The study involved 18 leading global centers including Mayo Clinic, University of Chicago, Brigham and Women’s, Columbia and more. This breakthrough shows the potential for AI to help clinicians detect cardiac amyloidosis earlier, differentiate it from similar conditions like HFpEF or hypertrophic cardiomyopathy, and expand access to life-changing therapies. This is another important milestone for @ultromics as we continue to transform cardiovascular care with AI — not just through EchoGo® Amyloidosis, but also through our EchoGo® Heart Failure platform. 🔗 Full Publication: academic.oup.com/eurheartj/a… With gratitude to our incredible collaborators: @pattypellikka @JSlivnickMD Will Hawkes @sarahcud @DocStrom @AshleyAkerman And a heartfelt tribute to the late Roberto Lang, whose leadership and vision helped make this work possible. His legacy continues through innovations like this ❤️ @ESC_Journals @escardio @ASE360 #EHJ #Echofirst #CardiacAmyloidosis #HeartFailure #AIinHealthcare #MedTech #Cardiology #DigitalHealth #EchoGo #Ultromics #Innovation #HFpEF #CardiovascularAI
1
4
11
1,301
Evuzamitide.... Creo que por acá viene el futuro de la marcación de amiloidosis cardíaca. Marcador específico con capacidad de cuantificar.... jacc.org/doi/10.1016/j.jcmg.…
7
16
1,024
Daniel Quesada retweeted
Replying to @adribaran
Amazing Congress, on the basis of academic leadership, emerging young investigators, mentoring and friendship. The result of each member effort. Congratulations SIAC for representing the Heart of the America’s
2
7
142
What a privilege to have to opportunity to give this award to Professor Valentin Fuster during his visit to Colombia in SIAC2025 meeting , @upbcolombia Doctorado Honoris causa for his amazing work in cardiology.
6
11
1
67
3,023
¡HOY! 🕑 14:00 horas. 32 Congreso Interamericano de Cardiología - SIAC 2025. Invitados a la presentación de E-Pósters sobre insuficiencia cardíaca. #CongresoSIAC25 @SIAC_cardio @SIAComunidad @cifacah @CongresoSIAC @EmergenciasSiac @sccccardio @FallaCardiaca
2
5
324
Excelentes conferencias. Grandes oportunidades para mejora de las revistas cardiológicas latinoamericanas. @APCyCCV
1
5
107
En el día 3 del #CongresoSIAC @SIAC_cardio En la sesión de Insuficiencia aguda de @cifacah estuve hablando sobre Estrategias para optimizar la terapia depletiva Es un honor y un gusto ser parte de este evento en Cartagena, Colombia 🇨🇴 ☺️ @RiveraToquicaMD @drjegomez @VergesAna @paomorejon @drdquesada
1
6
19
317
Mesa @cifacah #CongresoSIAC “Empeoramiento (Worsening) de la insuficiencia cardíaca” ¿Es de utilidad el cateterismo cardíaco en el paciente en etapa de empeoramiento? Dra Luisa Aguilera Mora @drdquesada @RiveraToquicaMD @rossel_victor @paomorejon @SIAC_cardio @cifacah @adribaran
7
18
630
Daniel Quesada retweeted
Be counted! @ICCPR_GlobalCR is updating their #GlobalCardiacRehabAudit. Help us enumerate #cardiacrehab need in your country. Click here for informed consent and survey (use Google Translate if needed): redcap.apps01.yorku.ca/surve…. Participate today and earn free access to become #ICCPRcertified!
2
6
3
11
1,279
Colombia te espera! Faltan 6 días para el #CONGRESOSIAC 2025 en la Ciudad de Cartagena 🇨🇴 ⁦@cifacah⁩ ⁦@rossel_victor⁩ ⁦@RiveraToquicaMD⁩ @Walarco1 ⁦@jorge_thierer⁩ ⁦@clara_clarais⁩ @SAC⁦@SAC_54⁩ 54 ⁦@ComunidadFAC⁩
6
1
15
757
Alianza Contra la Muerte Súbita, una iniciativa de la ⁦@SIACardio⁩ ⁦@SIAC_cardio⁩
2
4
9
401